BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9260911)

  • 1. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
    Larraín J; Alvarez J; Hassell JR; Brandan E
    Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and processing of glypican during differentiation of skeletal muscle cells.
    Brandan E; Carey DJ; Larraín J; Melo F; Campos A
    Eur J Cell Biol; 1996 Oct; 71(2):170-6. PubMed ID: 8905294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
    Dodge GR; Boesler EW; Jimenez SA
    Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
    Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
    J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
    Nerlich A
    Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation.
    Smith SE; French MM; Julian J; Paria BC; Dey SK; Carson DD
    Dev Biol; 1997 Apr; 184(1):38-47. PubMed ID: 9142982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of proteoglycans during limb myogenic activation.
    Olguin H; Brandan E
    Dev Dyn; 2001 May; 221(1):106-15. PubMed ID: 11357198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity.
    Kishioka Y; Thomas M; Wakamatsu J; Hattori A; Sharma M; Kambadur R; Nishimura T
    J Cell Physiol; 2008 Jun; 215(3):856-67. PubMed ID: 18163379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing and subcellular distribution of the Schwann cell lipid-anchored heparan sulfate proteoglycan and identification as glypican.
    Carey DJ; Stahl RC; Asundi VK; Tucker B
    Exp Cell Res; 1993 Sep; 208(1):10-8. PubMed ID: 8395393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence.
    Carson DD; Tang JP; Julian J
    Dev Biol; 1993 Jan; 155(1):97-106. PubMed ID: 8416848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
    Mathiak M; Yenisey C; Grant DS; Sharma B; Iozzo RV
    Cancer Res; 1997 Jun; 57(11):2130-6. PubMed ID: 9187109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan gene expression precedes laminin gene expression during differentiation of F9 embryonal carcinoma cells.
    Chakravarti S; Hassell JR; Phillips SL
    Dev Dyn; 1993 Jun; 197(2):107-14. PubMed ID: 8219353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
    Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
    Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of perlecan proteoglycan in metastatic melanomas.
    Cohen IR; Murdoch AD; Naso MF; Marchetti D; Berd D; Iozzo RV
    Cancer Res; 1994 Nov; 54(22):5771-4. PubMed ID: 7954396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.